| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0713 |
| Trial ID | ACTRN12619000079145 |
| Disease | Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Safety of Immune Cells for Patients with Relapsed Leukaemia or Lymphoma after Chemotherapy |
| Year | 2019 |
| Country | Australia |
| Company sponsor | Western Sydney Local Health District, Westmead Hospital |
| Other ID(s) | U1111-1226-8682 |
| Cohort 1 | |||||||||||||
|
|||||||||||||